Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
Oolong tea containing L-arabinose and indigestible dextrin
Oolong tea (Placebo)
Sponsored by

About this trial
This is an interventional prevention trial for Obesity
Eligibility Criteria
Inclusion Criteria:
- Healthy as based on medical history and physical examination
- BMI between 25 and 30 kg/m2
- Willing not to serve as blood donor during the study
- Informed consent signed
Exclusion Criteria:
- Female subjects who are pregnant or nursing a child
- Participation in any clinical trial up to 90 days before Day 01 of this study
- Renal or hepatic dysfunction
- Heart disease
- Under medication
- Subjects who are taking functional food designed for weight loss or serum lipid reduction
Sites / Locations
- Hiroshima University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
1
2
Arm Description
Outcomes
Primary Outcome Measures
Body mass index
Secondary Outcome Measures
Body fat mass
Abdominal circumference
Visceral fat area by CT scan
Serum lipid profile
Serum adiponectin and leptin levels
Fasting serum glucose and HbA1c levels
Frequency of bowel movement
Full Information
NCT ID
NCT00880646
First Posted
April 13, 2009
Last Updated
October 28, 2009
Sponsor
Hiroshima University
Collaborators
Unitika Ltd.
1. Study Identification
Unique Protocol Identification Number
NCT00880646
Brief Title
Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity
Official Title
Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity: a Double-Blind, Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2009
Overall Recruitment Status
Completed
Study Start Date
March 2009 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
October 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Hiroshima University
Collaborators
Unitika Ltd.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on body mass index, body fat mass, abdominal circumference, visceral fat mass, and serum biochemical parameters in overweight subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
70 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Title
2
Arm Type
Placebo Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
Oolong tea containing L-arabinose and indigestible dextrin
Intervention Type
Dietary Supplement
Intervention Name(s)
Oolong tea (Placebo)
Primary Outcome Measure Information:
Title
Body mass index
Time Frame
20 weeks
Secondary Outcome Measure Information:
Title
Body fat mass
Time Frame
Every 4 weeks (Overall 20 weeks)
Title
Abdominal circumference
Time Frame
Every 4 weeks (Overall 20 weeks)
Title
Visceral fat area by CT scan
Time Frame
Week 0, Week 12
Title
Serum lipid profile
Time Frame
Every 4 weeks (Overall 20 weeks)
Title
Serum adiponectin and leptin levels
Time Frame
Week 0, Week 12
Title
Fasting serum glucose and HbA1c levels
Time Frame
Every 4 weeks (Overall 20 weeks)
Title
Frequency of bowel movement
Time Frame
20 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy as based on medical history and physical examination
BMI between 25 and 30 kg/m2
Willing not to serve as blood donor during the study
Informed consent signed
Exclusion Criteria:
Female subjects who are pregnant or nursing a child
Participation in any clinical trial up to 90 days before Day 01 of this study
Renal or hepatic dysfunction
Heart disease
Under medication
Subjects who are taking functional food designed for weight loss or serum lipid reduction
Facility Information:
Facility Name
Hiroshima University
City
Hiroshima
ZIP/Postal Code
734-8551
Country
Japan
12. IPD Sharing Statement
Learn more about this trial
Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity
We'll reach out to this number within 24 hrs